This study, based on responses to a questionnaire, was undertaken to d
efine problems in and formulate solutions for improving blood safety i
n developing countries as part of an effort to monitor the status of b
lood transfusion services globally. Despite improvements between 1988
and 1992, only 66% of developing countries (DGCs) and 46% of least dev
eloped countries (LDCs) screen all blood donations for antibodies to h
uman immunodeficiency viruses; 72% DGCs and 35% LDCs test all donation
s for hepatitis B surface antigen and 71 and 48%, respectively, for sy
philis. The antihuman globulin test is performed routinely in 62% DGCs
and 23% LDCs, and inadequate quality assurance in all aspects of prep
aratory testing is a major weakness in many countries. The blood suppl
y is usually insufficient: none of the LDCs and 9% of the DGCs collect
30 units or more per 1,000 of the population annually. Blood donor sy
stems are totally voluntary and non-remunerated in 15% DGCs and 7% LDC
s; 80% DGCs and 93% LDCs rely totally or partially on replacement dono
rs and 25% of both groups on paid donations. The proportion of repeat
donors is low (medians: 47% in DGCs, 20% in LDCs), and discard rates f
or collected blood are often high (up to 33%). Most of the blood colle
cted is transfused as whole blood, and most DGCs and LDCs have inadequ
ate supplies of plasma substitutes for management of acute haemorrhage
. The reasons for these problems and suggested solutions are discussed
.